Last month, some analysts reviewed their ratings of Novo Nordisk shares.
13 analysts revealed their assessment of Novo Nordisk shares.
8 experts classify the Novo Nordisk share as a buy, 3 experts recommend holding the share, 2 experts rate the share as a sell.
On average, analysts see a price target of DKK 749.23 for Novo Nordisk. This means an increase of CHF 699.56 compared to the current SWX price of CHF 49.67.
The 6-month rating trend is Buy.
| Analyst | Price target | Distance price target | Date | |
|---|---|---|---|---|
| JP Morgan Chase & Co. | 850.00 DKK | 1,611.29 | January 31, 2024 | |
| UBS AG | 795.00 DKK | 1,500.56 | January 31, 2024 | |
| Jefferies & Company Inc. | 465.00 DKK | 836.18 | January 31, 2024 | |
| UBS AG | 795.00 DKK | 1,500.56 | January 30, 2024 | |
| JP Morgan Chase & Co. | 850.00 DKK | 1,611.29 | 01/24/2024 | |
| Barclays Capital | 825.00 DKK | 1,560.96 | January 17, 2024 | |
| Jefferies & Company Inc. | 500.00 DKK | 906.64 | January 16, 2024 | |
| UBS AG | 795.00 DKK | 1,500.56 | January 15, 2024 | |
| JP Morgan Chase & Co. | 850.00 DKK | 1,611.29 | 01/12/2024 | |
| Deutsche Bank AG | 850.00 DKK | 1,611.29 | 01/10/2024 | |
| JP Morgan Chase & Co. | 850.00 DKK | 1,611.29 | January 8, 2024 | |
| Jefferies & Company Inc. | 465.00 DKK | 836.18 | 01/03/2024 | |
| JP Morgan Chase & Co. | 850.00 DKK | 1,611.29 | 02/01/2024 |
Editorial team finanzen.net
Selected leverage products on Novo Nordisk
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Novo Nordisk
The leverage must be between 2 and 20
Advertising